Table 1.
Proband | Mother | |
---|---|---|
Oral glucose tolerance test | ||
C‐peptide (ng/mL) | ||
Pre | 0.85 | |
30 min | 2.53 | |
60 min | 2.77 | |
120 min | 1.79 | |
Glucose (mg/dL) | ||
Pre | 121 | |
30 min | 199 | |
60 min | 321 | |
120 min | 323 | |
ΣCPR (ng/mL) | 8.6 | |
Arginine challenge test | ||
C‐peptide (ng/mL) | ||
Pre | 0.85 | |
30 min | 2.53 | |
60 min | 2.77 | |
120 min | 1.79 | |
Glucagon (pg/mL) | ||
Pre | 113 | |
30 min | 521 | |
60 min | 365 | |
120 min | 134 | |
Glucagon challenge test | ||
Glucose (mg/dL) | ||
Pre | 98 | 94 |
Post | 131 | 105 |
C‐peptide (ng/mL) | ||
Pre | 1.0 | 1.8 |
Post | 2.2 | 2.6 |
Plasma glucose or glucagon as well as serum C‐peptide concentrations before and 30, 60 or 120 min after the oral administration of glucose (75 g) or intravenous administration of arginine (0.5 g/kg) were measured. Plasma glucagon was measured with a radioimmunoassay (BML, Tokyo, Japan). For the glucagon challenge test, glucagon (1 mg) was injected intravenously after the participants had been deprived of food overnight, with plasma glucose and serum C‐peptide being measured before (pre) and 6 min after (post) the injection. ΣCPR, sum of serum C‐peptide immunoreactivity.